Cargando…

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC), the most aggressive renal cancer, is characterized by early lymph node metastases and bad prognosis. Most therapies targeting advanced or metastatic ccRCC are based, as first-line treatment, on the administration of the vascular endothelial growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	García, Marcela, Palma, Maria Belen, Verine, Jerome, Miriuka, Santiago, Inda, Ana M., Errecalde, Ana L., Desgrandchamps, François, Carosella, Edgardo D., Tronik-Le Roux, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333411/ https://www.ncbi.nlm.nih.gov/pubmed/32620162 http://dx.doi.org/10.1186/s12885-020-07113-8

Ejemplares similares

Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients
por: Tronik‐Le Roux, Diana, et al.
Publicado: (2017)

HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy
por: Palma, María Belén, et al.
Publicado: (2021)

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8(+) T cells
por: Desgrandchamps, Francois, et al.
Publicado: (2018)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
por: Schwich, Esther, et al.
Publicado: (2020)

Wound Healing by Allogeneic Transplantation of Specific Subpopulation From Human Umbilical Cord Mesenchymal Stem Cells
por: Palma, María Belén, et al.
Publicado: (2021)

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
por: Wu, Ching-Lien, et al.
Publicado: (2021)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
por: Chen, Qiong-Yuan, et al.
Publicado: (2021)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
por: Lin, Aifen, et al.
Publicado: (2021)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells
por: Paavola, Kevin J., et al.
Publicado: (2021)

Non-classical transcriptional regulation of HLA-G: an update
por: Moreau, Philippe, et al.
Publicado: (2010)

Non-classical transcriptional regulation of HLA-G: an update
por: Moreau, Philippe, et al.
Publicado: (2009)

Differences in the Expression of KIR, ILT Inhibitory Receptors, and VEGF Production in the Induced Decidual NK Cell Cultures of Fertile and RPL Women
por: Kniotek, Monika, et al.
Publicado: (2021)

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance
por: ZHANG, YI, et al.
Publicado: (2012)

The Dual Role of HLA-G in Cancer
por: Rouas-Freiss, Nathalie, et al.
Publicado: (2014)

Osteodifferentiated Mesenchymal Stem Cells from Bone Marrow and Adipose Tissue Express HLA-G and Display Immunomodulatory Properties in HLA-Mismatched Settings: Implications in Bone Repair Therapy
por: Montespan, Florent, et al.
Publicado: (2014)

Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2
por: Yaghi, Layale, et al.
Publicado: (2016)

Human Keratinocytes Inhibit CD4(+) T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints
por: Mestrallet, Guillaume, et al.
Publicado: (2021)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment
por: Wu, Danli, et al.
Publicado: (2015)

ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression
por: Yang, Zijiang, et al.
Publicado: (2021)

Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity
por: Gao, Aiqin, et al.
Publicado: (2021)

Haplotypes of the HLA-G 3’ Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially
por: Poras, Isabelle, et al.
Publicado: (2017)

A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement
por: Luzzani, Carlos, et al.
Publicado: (2015)

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
por: Villa-Álvarez, Mónica, et al.
Publicado: (2018)

Air sampling for detection of infectious laryngotracheitis (ILT) in commercial poultry flocks
por: Brown, Lauren, et al.
Publicado: (2020)

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
por: Palma dos Reis, Ana Filipa, et al.
Publicado: (2022)

Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies
por: Lugand, Leonard, et al.
Publicado: (2022)

Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis
por: Bergamini, Alberto, et al.
Publicado: (2014)

A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing
por: Cella, Marina, et al.
Publicado: (1997)

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
por: Cao, Wei, et al.
Publicado: (2009)

Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review
por: Chawki, Sylvain, et al.
Publicado: (2015)

Bladder cancer in HIV-infected adults: an emerging concern?
por: Chawki, Sylvain, et al.
Publicado: (2014)

Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18
por: Willcox, Benjamin E, et al.
Publicado: (2002)

Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G
por: Lombard, Catherine A., et al.
Publicado: (2019)

Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo
por: Favier, Benoit, et al.
Publicado: (2011)

Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4
por: Lu, Ning, et al.
Publicado: (2018)

Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience
por: Andacoglu, Oya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tgrdg42fic6ofvn02bgdtn03td